Congressional commission warns of US pharma dependence on China’s innovation

The National Security Commission on Emerging Biotechnology warned in a Nov. 18 brief that China is working to control the pharmaceutical supply chain, from manufacturing to drug discovery, and that U.S. drugmakers’ growing licensing deals with Chinese biotechs are deepening American dependence. The commission, a congressional body, said China published a pharmaceutical-focused follow-on to its […] The post Congressional commission warns of US pharma dependence on China’s innovation appeare...

Original Source

Read the full article at Beckershospitalreview →

KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.